Coronary Revascularisation by rePOT
CABRIOLET
Coronary Artery Bifurcation Revascularization Without kIssing ballOon infLation by rEpoT: The CABRIOLET Study
1 other identifier
observational
500
1 country
4
Brief Summary
The presence of a coronary bifurcation complicates percutaneous revascularization. Bifurcation stenting needs to take into account the difference of diameter between proximal and distal vessels and the necessity to limit the side branch obstruction. Provisional stenting techniques with balloon juxtaposition as Kissing Balloon Inflation (KBI) fail to demonstrate a clinical benefits. This is probably explain by the detrimental effect during these technics on the proximal segment with an arterial overstretch. A new sequential technique, named rePOT, demonstrated experimentally a mechanical superiority compared to juxtaposition balloon techniques included KBI. RePOT associates an initial proximal optimizing technique (POT), a side branch inflation and a final POT. A first clinical study (n=106 patients) confirmed these excellent mechanical results with serial OCT analysis and demonstrated an excellent short term safety. Since 2017, rePOT is recommended in Europe in clinical practice. This large registry is dedicated to confirm the clinical benefits at long term after bifurcation revascularization with rePOT technique before a large randomise trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2018
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2018
CompletedFirst Submitted
Initial submission to the registry
May 15, 2018
CompletedFirst Posted
Study publicly available on registry
June 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 23, 2022
CompletedApril 11, 2024
April 1, 2024
4.1 years
May 15, 2018
April 10, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.
Number of deaths
At 12 months
Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.
Number of myocardial infections
At 12 months
Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.
Number of stent thrombosis
At 12 months
Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.
Number of target lesion revascularization
At 12 months
Interventions
All revascularizations have to be performed with complete rePOT technique: initial POT + side branch inflation + final POT. Compliant or semi compliant balloon have to be preferred to inflations. The POT balloon positioning have to be precise as obtain the loose of the parallelism just at the carina cut plan. The rest of the medication or procedure characteristics stay at the discretion of the operator. The follow-up will be clinic every years.
Eligibility Criteria
All patient with stable coronary lesion interesting a bifurcation with indication of revascularization (angiographique or functional) by provisional stenting technique can be included.
You may qualify if:
- Discovery, during angiography, of a significant coronary lesion (by angiographic or functional assessment) including a bifurcation under a provisional stenting strategy. Bifurcation have to be significant according to the operator and the coronary anatomy (but the side branch diameter have to be greater than 1.75mm)
- Stable lesion without high thrombus burden
- Patient agreement to study participation and ≥ 18 years
You may not qualify if:
- Complex lesion or anatomy requiring revascularization strategy with more than one stent
- Contraindication to a double platelet anti-aggregation ≥ 6mois (recommended implantation of active stent)
- Unstable patient according to the operator (used of hemodynamic drug support, mechanical ventilation)
- Indication of cardiac surgery.
- Lesion culprit in ST- or non ST-elevation myocardial infarction \<12h.
- High thrombus burden in angiography or endocoronary imaging (IVUS, OCT).
- Pregnancy, loose of legal right
- Other interventional study participation \<30 jours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Département de cardiologie Clinique Axium
Aix-en-Provence, 13090, France
Fédération de cardiologie médicale - Hôpital Cardiologique Louis Pradel - Hospices civils de Lyon
Bron, 69500, France
Département de cardiologie Hôpital Gabriel Montpied CHU de Clermont Ferrand
Clermont-Ferrand, 63003, France
Département de cardiologie CHU de Nimes
Nîmes, 30029, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2018
First Posted
June 8, 2018
Study Start
May 14, 2018
Primary Completion
June 23, 2022
Study Completion
June 23, 2022
Last Updated
April 11, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share